John Simboli

Please save the date for the opening reception of my new #photography and #video exhibit on the evening of October 13 at Five Points Gallery Annex, 33 Main St., Torrington, CT @5pointsgallery #art, #artist, #FineArt, #FineArtPhotography, #fineartvideo, #filmmaking

Pre-Order Now: Born Under A Rhyming Planet - Diagonals DDS bleep.com/release/324330 + Violet vinyl + Mastered by Rashad Becker + Limited to 500

New BioBoss podcast bioboss.news/KevinLee Kevin Lee, #CEO @Bicycle_tx with #bioboss host @WSGJohn. #leadership in #biopharma #biotech,#biopharma,#openscience,#innovation,#BioBoss,#therapeutics,#cancer,#immuno-oncogy,#peptide,#BicyclicPeptides,#scaffolds,#drugdevelopment,#BTC

Orexo´s novel and innovative drug delivery platform amorphOX will serve as the backbone in the development of our future pharmaceuticals. The applicability is wide as it can be used with different: 1️⃣APIs 2️⃣Dosage forms 3️⃣Administration routes #orexo #innovation

Join us next week as Derek Maetzold, president and CEO, and Frank Stokes, CFO, present a company overview at the 21st Annual Needham Virtual Healthcare Conference. Tuesday, April 12 at 3:00 p.m. ET. Register for the live audio webcast: bit.ly/CSTLevents

#NEWS: Today, we announced the publication of results from a Phase 3 #clinicaltrial evaluating our investigational oral carbapenem #antibiotic in @NEJM. Learn more about the paper: investors.sperotherapeutics.com/news-releases/…

Anima’s high scale phenotypic screening is running 24/7 in our automated #biology lab🔬generates millions of #mRNA translation images. The system identifies the drugs MOA by #AI analysis. We established 18 pipeline programs and big pharma partnerships🤝 bit.ly/3JakjEo

GET TO KNOW #OREXO – the 2021 Annual Report is out. It gives a deeper knowledge about the company, our business landscape & financial development. It also includes the Sustainability Report, which outlines major steps taken to contribute to a more sustainable society #ESEF

#BioBoss #podcast lnkd.in/dcu9PssZ Reenie McCarthy, #CEO @StealthBT. @reeniemccarthy speaks with BioBoss host John Simboli about #leadership in #biopharma #AMD #rarediseases #MitochondrialDisease #mitochondria $MITO #GA #cardiomyopathy #BarthSyndrome #LHON #Duchenne #DMD

New BioBoss podcast bioboss.news/BobCobuzzi Bob Cobuzzi, CEO, Diffusion Pharmaceuticals #CEO,#biotech,#biopharma,#openscience,#innovation,#therapeutics,#hypoxia,#VA,#UVA,#TSC,#carotenoid,#diffusion,#plasma,#oxyen,#oxygenation,#oxygendiffusion,#DFFN,#leadership,@BioBossPodcast

I enjoyed my #BioBoss podcast conversation with Panna Sharma, #CEO of #LanternPharma, bioboss.news/PannaSharma and his perspective on #leadership in #biopharma and the intersection of #AI, #genomics and #machinelearning.

@RoivantDiscover is using quantum physics-based molecular dynamics simulation to rationally design small molecule drugs & AlphaFold2 is a step forward in the computational understanding of protein biology. CTO Huafeng Xu’s blog post regarding their research is super interesting!

Meet Abe, 1 of just 130 children and young adults in the U.S. living with #BarthSyndrome. Share his family’s video highlighting their experience living with a #raredisease. Help raise their voices to those who determine access to treatment options @US_FDA bit.ly/AbeStoryBSF

Latest #BioBoss #podcast, Lantern Pharma CEO Panna Sharma, bioboss.news/PannaSharma Hear my conversation with Panna about #leadership in #biopharma and how Lantern Pharma is working at the intersection of artificial intelligence, genomics and machine learning

News: @US_FDA clears clinical use of VB-111 produced in @VBLTherapeutic Modi'in, Israel facility & company resumes US patient enrollment in Ph3 OVAL trial. tinyurl.com/7wm3mwp7 $vblt #clinicaltrials #fda #cmc #oncology #OvarianCancer

#ICYMI: @PharmaReview featured an article on how we’re building a broad pipeline of genetically targeted, oral therapies for HLA-associated autoimmune diseases using our IMT-HALT small molecule drug discovery & development platform. Read the article here: bit.ly/32CWEcX

Enjoyed my #BioBoss podcast bioboss.news/NandanPadukone conversation with Nandan Padukone, CEO of IM Therapeutics. Hear Nandan's thoughts about #leadership in #biopharma and how IM Therapeutics is targeting the root cause of #autoimmunity with human leukocyte antigen #HLAs

Thank you to everyone who tuned in to @PBS @PBSAmerMasters last night for the premiere of 'Buddy Guy: The Blues Chase The Blues Away". If you missed it, you can watch the full episode online here. - Team BG pbs.org/video/buddy-gu…

"Funny thing about the blues -- you play 'em 'cause you got 'em. But when you play 'em, you lose 'em." ‘Buddy Guy: The Blues Chase The Blues Away’ TONIGHT on @PBS @PBSAmerMasters. Check your local listings. bit.ly/BuddyGuyTBCTBA - Team BG